Endocrinologist Dr. Richard L. Lipman, M.D.

Dr. Richard L. Lipman, M.D. is a board certified endocrinologist and internist specializing in medical weight loss. For the past 40 years, he has treated patients for metabolic disorders and weight problems in his South Miami, FL office. Dr. Lipman has spent his entire medical career developing personalized weight loss programs for his patients. He is one of the few endocrinologists in South Florida that treats overweight and obese patients.

Dr. Lipman has written ten books on weight loss and FDA approved weight loss medications. He has authored more than 26 professional publications in multiple medical journals.

Education & Professional Background

Dr Lipman did his endocrinology and weight loss training at Jackson Memorial Hosptial in Miami, Fl. Dr. Lipman received a degree in biochemistry from the University of Pittsburgh, where he was elected to Phi Beta Kappa. He received an MD in 1966 from the University Of Pittsburgh School Of Medicine, where he was elected to the Alpha Omega Alpha Honorary Medical Society as one of the top five members of his medical class. Dr. Lipman did his internship and residency in internal medicine at the University Of Pittsburgh Medical Center Hospitals. Further postgraduate training included a two-year fellowship in endocrinology and metabolism at the University of Miami School of Medicine–Jackson Memorial Hospital. While at the University of Miami, he authored and coauthored 15 publications in the areas of glucose and growth hormone metabolism.

Military Service

Dr. Lipman also spent two years at the United States Air Force School of Aerospace Medicine, where he was Assistant Chief of Endocrinology, and was a staff member of the Endocrinology Division at the USAF Hospital in San Antonio, Texas. While in the Air Force, Dr. Lipman authored six publications on the effects of prolonged weightlessness on glucose and protein metabolism.

Private Practice

Following his Air Force assignments, Dr. Lipman began his private practice in endocrinology and metabolism in Miami, Florida. For the past 40 years he has focused his endocrinology practice on the treatment of obesity and metabolism-related problems – and has treated over 40,000 individuals with weight problems and endocrine disorders including thyroid and diabetic problems. Dr. Lipman is a staff member of Larkin and Cedars Hospital in Miami, a charter member of the American Association of Clinical Endocrinologists, a member of the American Diabetes Association, and a member of the American Association of Bariatric Physicians.

Dr. Lipman gives seminars in weight management at local hospitals and to employee groups of local businesses. He also participated in a series of interviews on a local Comcast cable television channel. Dr. Lipman currently lives with his wife in Miami, Florida, as he has for the past 40 years. He enjoys fishing and babysitting his five grandchildren.

Research

Over seven years, Dr. Lipman closely followed 375 of his obese patients who, as a group, lost an average of 22 pounds (ranging between 18 and 120 pounds) and kept their weight off for more than two years. His objective was to uncover the factors responsible for their success. This was the largest group of successful weight loss individuals that were treated by the same treating physician as reported in the literature. (All previously reported studies were retrospective reports obtained by questionnaires.) The results were published in April 2007 in the Journal of the American Bariatric Association.

Professional Associations

Dr. Lipman’s Journal Publications

Search All Publications on Google Scholar

1. Lipman, R.L. Exenatide and Weight Loss. American Journal of Bariatric Medicine. 25:15, 2009.
2. Lipman, R.L. The Healthy Aura: Is Eating Low Fat, Lite, Low Carb or Healthy Preventing Americans from Losing Weight? American Journal of Bariatric Medicine. 22(1):18–23, 2007
3. Lipman, R.L. Exenatide in the Treatment of Morbid Obesity. Accepted for publication, American Journal of Bariatric Medicine. Sept 2007.
4. Lipman, J.M., Lipman, R.L. The Tape Measure or the Scale: Physicians Guide to Measurement of Obesity. Submitted for publication, Postgraduate Medicine. July 2007.
5. Sapira, J.D., Lipman, R.L., and Shapiro, A.P.: Metabolic Change Secondary to Restraint. Psychosomatic Medicine 26:633, 1964.
6. Sapira, J.D., Lipman, R.L., and Shapiro, A.P.: The Effect of Restraint on Free Fatty Acid Mobilization in Rats. Psychosomatic Medicine 27:165, 1966.
7. Lipman, R.L., Tyrell, E., Small, J., and Shapiro, A.P.: Evaluation of Antibiotic Therapy in E. Coli Pyelonephritis in Rats. J. Lab. and Clin. Med. 67:546, 1966.
8. Lipman, R.L., Johnson, B., Berg, G., and Shapiro, A.P.: Idiopathic Retroperitoneal Fibrosis in a Patient with Probable Systemic Lupus Erythematosus. J. Amer. Med. Assoc. 196:204, 1965.
9. Sapira, J.D., Lipman, R.L., and Shapiro, A.P.: Hyperresponsivity to Angiotensin Induced in Rats by Behavioral Stimulation. Proc. Soc. Exp. Biol. Med.123:52, 1966.
10. Lipman, R. L., and Shapiro, A. P.: Effects of Behavioral Stimulation on Blood Pressure of Rats with Experimental Pyelonephritis. Psychosomatic Medicine 29:6, 1967.
11. Lipman, R.L., and Shapiro, A.P.: Experimental Pyelonephritis in DCA-Hypertensive Rats: Effect of Antibiotic Therapy on the Acceleration of the Hypertension. Investigative Urology 7:521, 1970.
12. Lipman, R. L., Raskin, P., and Preuss, H.: Failure of Cirrhotic Sera to Inhibit Renal Tubule Hippurate Transport In Vitro. Proc. Soc. Experimental Biology and Medicine. 131(3):936-938, 1969.
13. Lipman, R.L., McDonald, R.H., and Shapiro, A.P.: Insoluble Oxytetracycline in Experimental Pyelonephritis: Studies on the Role of Antibiotic Persistence in the Kidney. Chemotherapy 16:300–312, 1971.
14. Lipman, R.L., Schnure, J., Bradley, E., and Lecocq, F.R.: Impairment of Peripheral Glucose Utilization in Normal Subjects by Bed Rest. J. Lab. and Clin. Med. 76:221, 1970.
15. Lipman, R.L., Ulvedal, F., Schnure, J., Bradley, E., and Lecocq, F.R.: Gluco-regulatory Hormone Response to 2¬deoxy-D-Glucose Infusion in Normal Subjects. Metabolism 19:980, 1970.
16. Lipman, R.L., Ulvedal, F., Brown, W., Leverett, S., Lecocq, F. and Schnure, J.J.: Metabolic Response to Acceleration in Man. Aerospace Medicine 41:905, 1970.
17. Schnure, J. and Lipman, R.L.: Physiologic Studies of Growth Hormone Secretion During Sleep: Impairment in Glucose Tolerance and Nonsuppressibility by Hyperglycemia. J. Clin. Endo. and Metab. 33:234, 1971.
18. Love, T., Schnure, J., Larkin, W., Lecocq, F.R., and Lipman, R.L.: Glucose Intolerance in Man During Prolonged Exposure To A Hypobaric-Hyperoxic Environment. Diabetes 20:262, 1971.
19. Lipman. R.L., McDonald Jr., R.H., Connamacher, R.H., and Sharpio, A.P.: Studies of Antibiotic Persistence in the Therapy of Experimental Pyelonephritis: Insoluble Tetracyclines in Normal and Pyelonephritic Rats. Chemotherapy 16:300, 1971.
20. Raskin, P., Lipman, R.L., and Oloff, L.M.: Effect of Hyperbaric Oxygen On Liquid Peroxidation in the Lung. Aerospace Medicine 42:75, 1971.
21. Lipman, R.L., Raskin, P., Love, T., Triebwasser, Lecocq, F.R., and Schnure, J.J.: Glucose Intolerance During Decreased Physical Activity in Man. Diabetes 21:101, 1972.
22. Lipman, R.L., Raskin, P., Love, T., Lecocq, F.R., and Schnure, J.J.: Impairment in Peripheral Glucose Uptake by Decreased Physical Activity: Evidence for Peripheral Insulin Resistance. Diabetes 21:104, 1972.
23. Taylor, A., Lipman, R.L., Salem, A., and Mintz, D.H.: Hepatic Clearance of Growth Hormone in Normal Patients and in Patients with Laennec’s Cirrhosis. J. Clin. Endo. and Metab. 34:395, 1972.
24. Lipman, R.L., Taylor, A., Conly, P., and Mintz, D.H.: Metabolic Clearance Rate of Growth Hormone in Juvenile Onset Diabetes Mellitus. Diabetes 21:175, 1972.
25. Lecoco, F.R., Lipman, R.L., Leverett, S.D.: “Estimates of physiologic reserve after acceleration exposure in man (Human pituitary and adrenal hormone reserve in acceleration stress tolerance)“. Brussels, Belgium: North Atlantic Treaty Organization, Advisory Group for Aerospace Research and Development, 1972. 6p (SEE N 73-19143 10-05) Papers Presented at the AGARD Aerospace Medical Panel Specialist Meeting.
26. Lipman, R.L., Taylor, A.L., and Mintz, D.H.: Inhibition of Nocturnal Growth Hormone Release by Free Fatty Acids. J. Clin. Endo. and Metab. 35:592, 1972.
27. Bricker, L. and Lipman, R.: Hyperlipoproteinemias. Acta Dietologica Latina 9: Supp 2, Dec. 1972.
28. Ellis, J.P., Lecocq, F.R., Garcia, J.B., and Lipman, R.L.: Forearm Amino Acid Metabolism During Chronic Physical Inactivity. Aerospace Medicine 45 (1):15, 1974.

Abstracts

1. Sapira, J.D., Lipman, R.L., and Shapiro, A.P.: The Effect of Restraint On Free Fatty Acid Mobilization in Rats. Psychosomatic Medicine 26: 633, 1964. Presented at the Annual Meeting of the American Psychosomatic Society, April 1964, San Francisco, California.
2. Lipman, R.L. and Shapiro, A.P.: Evaluation of Antibiotics in Acute Pyelonephritis in: Rats. Clinical Research 14:311, 1966.
3. Sapira, J.D., Lipman, R. L., and Shapiro, A.P.: Hypersensitivity to Angiotensin Induced in Rats by Stress. Clinical “Research 14:44, 1965. Presented at the Southern Section, American Federation for Clinical Research, January 1966, New Orleans, Louisiana.
4. Lipman, R.L., Braude, A.I., and Shapiro, A.P.: Insoluble Tetracycline in Experimental Pyelonephritis. Proc. of the Third International Congress of Nephrology, September 1966. Presented at the Third Congress of Nephrology, Washington, D.C.
5. Lipman, R. L., Connamacher, R., McDonald, R.H., and Shaprio, A.P.: Renal Penetration of Insoluble and Soluble Tetracycline in Experimental Pyelonephritis. Clinical Research 16:389, 1968.
6. Lipman, R. L., Ulvedal, F., Schnure, J., Bradley, E. and Lecocq, R.: Gluco-regulatory Hormone Response to 2-Deoxy ¬D-Glucose Infusion in Normal Subjects. Clinical Research 17:590, 1969. Presented at the Eastern Section, American Federation for Clinical Research, December 1969.
7. Lipman, R.L., Ulvedal, F., Bradley, E. and Lecocq. R.: Inhibition of Peripheral Glucose Utilization by Bed rest. The Physiologist 12: 285, 1969. Presented at the annual meeting, American Physiological Association, Davis, California, August 1969.
8. Lipman, R.L., Love, T., Bradley, E., Lecocq, R., and Schnure, J.: Diminished Forearm Glucose Uptake in Subjects at Bed rest. Clinical Research 18:32, 1970. Presented at the Southern Section, American Federation for Clinical Research, New Orleans, Louisiana, and January 1970.
9. Lipman, R.L., Schnure, J., Love, T., and Lecocq, R.: Control of Glucose Metabolism at Bed rest in Man. Presented at the Annual Meeting of the United States Air Force Society of Physicians, San Antonio, Texas, February 1970.
10. Lipman, R. L., Schnure, J., Love, T., and Lecocq. R.: Diminished Forearm Glucose Uptake In Man at Bed rest. Presented at the National Meeting, American Federation for Clinical Research, Atlantic City, N.J., and May 1970.
11. Schnure, J., and Lipman, R.L.: Studies of Growth Hormone Secretion During Sleep: Nonsuppressibility by Hyperglycemia and Impairment: in Glucose Tolerance. Presented at the Annual Meeting of the Endocrine Society, St. Louis, Missouri, June 1970.
12. Love, T., Lipman, R., Schnure, J., Larkin, E., and Lecocq, R.: Glucose Intolerance in Man During Exposure to a Hypobaric-Hyperoxic Environment. Presented at the National Meeting of the American Diabetes Association, St. Louis’, Missouri, June 1970.
13. Lipman, R.L., Ulvedal, F., Bradley, E., Schnure, J., and Lecocq, R.: Metabolic Response to Acceleration. Presented at the Aerospace Medical Association Meeting, St. Louis, Missouri, April 1970.
14. Lecocq, F.R., Lipman; R.L.: Alterations in Glucose Insulin Interrelationships in Man at Bed rest. Presented at the Tenth Annual Meeting of the Mexican Society of Nutrition and Endocrinology, Acapulco, Mexico, December 1970.
15. Lipman, R.L., Schenk, A., Taylor, A.L., and Mintz, D.H.: Regulation of Growth Hormone Release: Effect of Estrogen on Feedback Control. Clinical Research 19:51, 1971.
16. Taylor, A.L., Lipman, R.L., and Mintz, D.H.: Peripheral and Hepatic Clearance of Growth Hormone in Humans. Presented at the Second International Growth Hormone Symposium, May 1971, Milan, Italy. Excerpta Medica 236:43, 1971.
17. Schnure, J.J., and Lipman, R.L.: Glucose Intolerance Following Growth Hormone Secretion During Sleep. Excerpta Medica 236:56, 1971.
18. Lipman, R.L., Taylor, A.L., and Mintz, D.H.: Hepatic Clearance of Growth Hormone in Humans: Clinical Research 19:478, 1971.
19. Lipman, R.L. Taylor, A. Schenk, A., and Mintz, D.H.: Dissociation of Deep Sleep Growth Hormone Release by Growth Hormone and Free Fatty Acids. Clinical Research 20:56, 1972.
20. Lipman, R.L., Taylor, A., Schenk, A., and Mintz, Acromegaly: A Disorder of Growth Hormone Feedback. Clinical Research 20:432, 1972.

Call 305-670-3259 to Make an Appointment with Endocrinologist, Internist, and Weight Loss Specialist Dr. Richard Lipman in his Miami Office